Hacker News new | ask | show | jobs
by programmarchy 1733 days ago
I hadn’t seen that paper, but isn’t your statement missing the forest for the trees? If pathology was attenuated, that would help patient recovery, even if viral load wasn’t directly reduced.

> Even though ivermectin had no effect on viral load, SARS-Cov-2-associated pathology was greatly attenuated. IVM had a sex-dependent and compartmentalized immunomodulatory effect, preventing clinical deterioration and reducing olfactory deficit in infected animals. Importantly, ivermectin dramatically reduced the Il-6/Il-10 ratio in lung tissue, which likely accounts for the more favorable clinical presentation in treated animals. Our data support IVM as a promising anti-COVID-19 drug candidate.

1 comments

Yes, it seemed like it worked in hamsters, but as we well know, most drugs that work in mice don't work in humans. Besides, we already have many anti-inflammatory drugs that can reduce the cytokines, so it's a stretch to use ivermectin strictly as a steroid.